SteraMist Takes the Fight to the Coronavirus Worldwide - China, Hong Kong, Thailand, Singapore, Israel and the United Kingdom

BEVERLY HILLS, Calif., Feb. 27, 2020 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQB:TOMZ), is a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products - a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (iHP). SteraMist has been deployed worldwide to combat coronavirus (COVID-19) through TOMI’s longstanding and new international partners and customers.

Already EPA-registered on lists J, K, G, and L, which include H1N1 or Influenza A (enveloped) and Norovirus (non-enveloped), TOMI anticipates to secure listing in the EPA’s upcoming publication of Emerging Pathogen Lists, which includes COVID-19. SteraMist was also featured as the only disinfectant product in the World Health Organization Compendium of Innovative Health Technologies.

SteraMist is now the industry standard throughout China after TOMI recently received approval and registration for two (2) separate registrations - SteraMist equipment registration and BIT solution registration - from the Chinese Center for Disease Control and Prevention (China CDC). With the latest outbreak, China is able to take advantage of SteraMist disinfection and its ability to rapidly deploy throughout the country as needed. TOMI is finalizing negotiations with high-level Chinese officials for use of the SteraMist Surface Unit in aiding the control of COVID-19.

Routinely used to disinfect high traffic areas, SteraMist iHP technology has treated public transportation, ambulances, hotel rooms, offices, and universities to stop the spread of this virus. With more than 50 international customers and partners ranging from countries in Asia, Europe, and the Mideast using hundreds of SteraMist units, many of which have been deployed to stop the spread of COVID-19.

Recently, TOMI has signed on a new distribution partner in Thailand, more news will be coming shortly. TOMI has also shipped a number of units to Hong Kong to assist with new innovative ways of helping Hong Kong with their ongoing battle of controlling COVID-19.

In addition to one of the many cases worldwide, a hotel in York became the first in the United Kingdom to test positive for COVID-19. After receiving approval from the Public Health of England, SteraMist was used to treat the hotel room and was quickly validated by Enzyme Indicators (EIs). The treatment was a resounding success: the room was disinfected with a 9-log inactivation, exceeding the 6-log inactivation required.